Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli
暂无分享,去创建一个
Shizhen Liu | D. Tang | F. Zheng | Jingquan He | Fanna Liu | L. Yin | Wenjun Pu | Huixuan Xu | Shan-Shan Li | Zhifeng Luo | Yong Dai | Jingjing Dong | Fengping Zheng
[1] W. Davis,et al. Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II , 2022, Diabetic medicine : a journal of the British Diabetic Association.
[2] C. Schmidt,et al. Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi‐protein cascade of the complement system , 2022, Immunological reviews.
[3] B. Rovin,et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.
[4] A. Kronbichler,et al. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] Yingwei Wang,et al. Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis , 2021, Experimental & Molecular Medicine.
[6] J. N. van den Anker,et al. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway , 2020, Frontiers in Immunology.
[7] Xuejun Zhang,et al. Quantitative proteomics analysis of young and elderly skin with DIA mass spectrometry reveals new skin aging-related proteins , 2020, Aging.
[8] N. Sheerin,et al. The role of complement in kidney disease. , 2020, Clinical medicine.
[9] Paul J. Hoover,et al. Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker. , 2020, JCI insight.
[10] Simon Youssef,et al. Quantitative modeling of synthetic gene transfer , 2011 .
[11] H. Debiec,et al. Molecular Pathogenesis of Membranous Nephropathy. , 2020, Annual review of pathology.
[12] S. Cha,et al. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis. , 2019, Kidney international.
[13] Z. Kopecki,et al. Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis , 2019, Scientific Reports.
[14] P. Cutillas,et al. Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling , 2019, Molecular oncology.
[15] W. Sandoval,et al. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis. , 2018, Journal of proteome research.
[16] Ming-hui Zhao,et al. Complement in glomerular diseases , 2018, Nephrology.
[17] Thomas Stoll,et al. Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II , 2017, Diabetes Care.
[18] F. Berven,et al. Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy , 2017, Clinical Proteomics.
[19] B. Ueberheide,et al. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease , 2017, Acta Neuropathologica.
[20] Ming-hui Zhao,et al. Complement Alternative Pathway's Activation in Patients With Lupus Nephritis , 2017, The American journal of the medical sciences.
[21] F. Kronenberg,et al. Association between apolipoprotein A‐IV concentrations and chronic kidney disease in two large population‐based cohorts: results from the KORA studies , 2015, Journal of internal medicine.
[22] R. Arkell,et al. Fibroblast‐specific upregulation of Flightless I impairs wound healing , 2015, Experimental dermatology.
[23] D. Bubeck. The making of a macromolecular machine: assembly of the membrane attack complex. , 2014, Biochemistry.
[24] G. Xing,et al. C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy , 2014, Journal of Clinical Immunology.
[25] T. Takano,et al. Complement-mediated cellular injury. , 2013, Seminars in nephrology.
[26] D. Zillikens,et al. Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. , 2013, The Journal of investigative dermatology.
[27] Y. Itoyama,et al. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica , 2013, Journal of Neuroimmunology.
[28] Anjali A. Satoskar,et al. A quantitative proteomic workflow for characterization of frozen clinical biopsies: laser capture microdissection coupled with label-free mass spectrometry. , 2012, Journal of proteomics.
[29] Wuding Zhou,et al. The role of complement in the early immune response to transplantation , 2012, Nature Reviews Immunology.
[30] R. Liddington,et al. Crystal Structure of C5b-6 Suggests Structural Basis for Priming Assembly of the Membrane Attack Complex* , 2012, The Journal of Biological Chemistry.
[31] W. Couser. Basic and translational concepts of immune-mediated glomerular diseases. , 2012, Journal of the American Society of Nephrology : JASN.
[32] D. Zillikens,et al. Overexpression of the Flii gene increases dermal–epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita , 2011, The Journal of pathology.
[33] C. Cudrici,et al. TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects. , 2009, Clinical immunology.
[34] Chunli Shao,et al. The roles of MAPKs in disease , 2008, Cell Research.
[35] P. Gasque,et al. Extrahepatic complement biosynthesis: where, when and why? , 1997, Clinical and experimental immunology.
[36] W. Couser,et al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. , 1991, Kidney international.
[37] Robert C. Wolpert,et al. A Review of the , 1985 .